Head and neck tumors other than squamous cell carcinoma

Current Opinion in Oncology

Volumn 16, Issue 3, 2004, Pages 236-241

  Licitra, Lisa ^a   Locati, Laura D ^a   Bossi, Paolo ^a   Cantù, Giulio ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

Paranasal sinus tumors; Salivary gland cancer; Sinonasal tract cancer

Indexed keywords

ANDROGEN RECEPTOR; ANTINEOPLASTIC AGENT; CISPLATIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; IFOSFAMIDE; PACLITAXEL; STEM CELL FACTOR RECEPTOR; TUMOR MARKER;

ADENOID CYSTIC CARCINOMA; CANCER CHEMOTHERAPY; CANCER CLASSIFICATION; CANCER STAGING; CLINICAL TRIAL; HEAD AND NECK CARCINOMA; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; INTENSITY MODULATED RADIATION THERAPY; LYMPH NODE METASTASIS; NEUROTOXICITY; PARANASAL SINUS CARCINOMA; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; REVIEW; SALIVARY GLAND CANCER; SQUAMOUS CELL CARCINOMA; TREATMENT OUTCOME;

CARCINOMA, ADENOID CYSTIC; CARCINOMA, SQUAMOUS CELL; HEAD AND NECK NEOPLASMS; HUMANS; NEOPLASM STAGING; PARANASAL SINUS NEOPLASMS; SALIVARY GLAND NEOPLASMS;

EID: 2142758079     PISSN: 10408746     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001622-200405000-00008     Document Type: Review

References (64)

1. Bradley P, Jones N, Robertson I: Diagnosis and management of esthesioneuroblastoma. Curr Opin Otolaryngol Head Neck Surg 2003, 11:112-118. This is a comprehensive review of esthesioneuroblastoma.
2. Ohngren LG: Malignant tumours of the maxillo-ethmoidal region. Acta Otolaryngol 1933, S19:101-106.
3. Lederman M: Tumors of the upper jaw: natural history treatment. J Laryngol Otol 1970, 84:369-401.
4. Sakai S, Hamasaki Y: Proposal for the classification of carcinoma of the paranasal sinuses. Acta Otolaryngol 1967, 63:42-48.
5. Carinci F, Farina A, Padula E, et al.: Primary malignancies of the nasal fossa and paranasal sinuses: comparison between UICC classification and a new staging system. J Craniofac Surg 1997, 8:405-412.
6. Cantù G, Solero CL, Mariani L, et al.: A new classification for malignant tumors involving the anterior skull base. Arch Otolaryngol Head Neck Surg 1999, 125:1252-1257.
7. Sobin LH, Wittekind C: UICC (International Union Against Cancer) TNM Classification of Malignant Tumours. Edn 6. New York: Wiley-Liss; 2002.
8. Patel SG, Singh B, Polluri A, et al.: Craniofacial surgery for malignant skull base tumors. Cancer 2003, 98:1179-1187. This paper presents the results of skull base surgery, a collaborative international review.
9. Bentz BG, Bilsky MH, Shah JP, et al.: Anterior skull basa surgery for malignant tumors: a multivariate analysis of 27 years of experience. Head Neck 2003, 25:515-520.
10. Suarez C, Liorente JL, De Leon RF, et al.: Prognostic factors in sinonasal tumors involving the anterior skull base. Head Neck 2004, 26:136-144.
11. Myers L, Nussenbaum B, Bradford C, et al.: Paranasal sinus malignancies: an 18-year single institution experience. Laryngoscope 2002, 112:1964-1969.
12. Feinstein AR, Sosin DM, Wells CK: The Will Rogers phenomenon. Stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer. New Engl J Med 1985, 312:1604-1608.
13. Silva EG, Butler JJ, Mac Kay B, et al.: Neuroblastomas and neuroendocrine carcinomas of the nasal cavity: a proposed new classification. Cancer 1982, 50:2388-2405.
14. Haas I, Ganzer U: Does sophisticated diagnostic workup on neuroectodermal tumors have an impact on the treatment of esthesioneuroblastoma? Onkologie 2003, 26:261-267.
15. Frierson HF, Mills SE, Fechner RE, et al.: Sinonasal undifferentiated carcinoma: an aggressive neoplasm derived from Schneiderian epithelium and distinct from olfactory neuroblastoma. Am J Surg Pathol 1986, 10:771-779.
16. Jeng J, Sung M, Fang C, et al.: Sinonasal undifferentiated carcinoma and nasopharyngeal-type undifferentiated carcinoma: two clinically, biologically and histopathologically distinct entities. Am J Surg Pathol 2002, 26:371-376.
17. Miyamoto RC, Gleich LL, Biddinger PW, et al.: Esthesioneuroblastoma and sinonasal undifferentiated carcinoma: impact of histological grading and clinical staging on survival and prognosis. Laryngoscope 2000, 110:1262-1265.
18. Franchi A, Moroni M, Massi D, et al.: Sinonasal undifferentiated carcinoma nasopharyngeal-type undifferentiated carcinoma and keratinizing and non-keratinizing squamous cell carcinoma express different cytokeratin patterns. Am J Surg Pathol 2002, 26:1597-1604.
19. Smith SR, Som P, Fahmy A, et al.: A clinicopathological study of sinonasal neuroendocrine carcinoma and sinonasal undifferentiated carcinoma. Laryngoscope 2000, 110:1617-1622.
20. Hyams VJ: Olfactory neuroblastoma. In Tumors of the Upper Respiratory Tract and Ear. Edited by Hyams VJ, Batsakis JG, Michaels L. Washington, DC: Armed Forces Institute of Pathology; 1988:240-248.
21. McElroy EA Jr, Buckner JC, Lewis JE: Chemotherapy for advanced esthesioneuroblastoma: the Mayo Clinic experience. Neurosurgery 1998, 42:1023-1028.
22. Choi HR, Sturgis EM, Rashid R, et al.: Sinonasal adenocarcinoma: evidence for histogenetic divergence of the enteric and nonenteric phenotypes. Hum Pathol 2003, 34:1101-1107.
23. Franquemont DW, Fechener RE, Mills SE: Histologic classification of sinonasal intestinal type adenocarcinoma. Am J Surg Pathol 1991, 15:388.
24. Barnes L: Intestinal-type adenocarcinoma of the nasal cavity and paranasal sinuses. Am J Surg Pathol 1986, 10:192-202.
25. Perrone F, Oggionni M, Birindelli S, et al.: TP53, p14ARF, p16INK4a and H-ras gene molecular analysis in intestinal type adenocarcinoma of the nasal cavity and paranasal sinuses. Int J Cancer 2003, 105:196-203.
26. Tiwari R, van der Wal J, van der Waal, et al.: Studies of the anatomy and pathology of the orbit in carcinoma of the maxillary sinus and their impact on preservation of the eye in maxillectomy. Head Neck 1998, 20:193-196.
27. McCary WS, Levine PA, Cantrell RW: Preservation of the eye in the treatment of sinonasal malignant neoplasms with orbital involvement. A confirmation of the original treatise. Arch Otolaryngol Head Neck Surg 1996, 122:657-659.
28. LoRusso P, Tapazoglou E, Kish JA, et al.: Chemotherapy for paranasal sinus carcinoma. A 10-year experience at Wayne State University. Cancer 1968, 62:1-5.
29. Rosen A, Vokes EE, Scher N, et al.: Locoregionally advanced paranasal sinus carcinoma. Favorable survival with multimodality therapy. Arch Otolaryngol Head Neck Surg 1993, 119:743-746.
30. Brasnu D, Laccourreye O, Bassot V, et al.: Cisplatin-based neoadjuvant chemotherapy and combined resection for ethmoid sinus adenocarcinoma reaching and/or invading the skull base. Arch Otolaryngol Head Neck Surg 1996, 122:765-768.
31. Björk-Eriksson T, Mercke C, Petruson B, et al.: Potential impact on tumor control and organ preservation with cisplatin and 5-fluorouracil for patients with advanced tumors of the paranasal sinuses and nasal fossa. A prospective pilot study. Cancer 1992, 70:2615-2620.
32. Licitra L, Locati LD, Cavina R, et al.: Primary chemotherapy followed by anterior craniofacial resection and radiotherapy for paranasal cancer. Ann Oncol 2003, 14:367-372.
33. Licitra L, Perrone F, Suardi S, et al.: TP53 status may predict pathological complete remission (pCR) to cisplatin + fluorouracil + leucovorin (PFL) in ethmoidal intestinal type adenocarcinoma (ITAC) treated with preoperative chemotherapy. Eur J Cancer 2002, S22.
34. Papadimitrakopoulou VA, Ginsberg LE, Graden AS, et al.: Intraarterial cisplatin with intravenous paclitaxel and ifosfamide as an organ-preservation approach in patients with paranasal sinus carcinoma. Cancer 2003, 98:2214-2223.
35. Nishino H, Ichimura K, Tanaka H, et al.: Results of orbital preservation for advanced malignant maxillary sinus tumors. Laryngoscope 2003, 113:1064-1069.
36. Tsien C, Eisbruch A, McShan D, et al.: Intensity-modulated radiation therapy (IMRT) for locally advanced paranasal sinus tumors: incorporating clinical decisions in the optimization process. Int J Radiat Oncol Biol Phys 2003, 55:776-784.
37. Lee N, Xia P, Fischbein NJ, et al.: Intensity-modulated radiation therapy for head and neck cancer: the USFC experience focusing on target volume delineation. Int J Radiat Oncol Biol Phys 2003, 57:49-60.
38. Fitzek MM, Thornton AF, Varvares M, et al.: Neuroendocrine tumors of the sinonasal tract. Cancer 2002, 94:2623-2634.
39. Gil Z, Abergel A, Spektor S, et al.: Quality of life following surgery for anterior skull base tumors. Arch Otolaryngol Head Neck Surg 2003, 129:1303-1309.
40. Fukuda K, Saeki N, Mine S, et al.: Evaluation of outcome and QoL in patients with craniofacial resection for malignant tumors involving the anterior skull base. Neurol Res 2000, 22:545-550.
41. Bhattacharyya N, Fried MP: Nodal metastasis in major salivary gland cancer: predictive factors and effects on survival. Arch Otolaryngol Head Neck Surg 2002, 128:904-908.
42. Seifert G, Sobin LH: The World Health Organization's histological classification of salivary gland tumors. A commentary on the second edition. Cancer 1992, 70:379-385.
43. Ellis GL, Auclair PL: Atlas of Tumor Pathology: Tumors of the Salivary Glands. Washington, DC: Armed Forces Institute of Pathology; 1995.
44. Brandwein MS, Ivanov K, Wallace DI, et al.: Mucoepidermoid carcinoma: a clinicopathologic study of 80 patients with special reference to histological grading. Am J Surg Pathol 2001, 25:835-845.
45. Korkmaz H, Yoo GH, Du W, et al.: Predictors of nodal metastasis in salivary gland cancer. J Surg Oncol 2002, 80:186-189.
46. Stennert E, Kisner D, Jungehuelsing M, et al.: High incidence of lymph node metastasis in major salivary gland cancer. Arch Otolaryngol Head Neck Surg 2003, 129:720-723.
47. Zbàren P, Schùpbach J, Nuyens M, et al.: Carcinoma of the parotid gland. Am J Surg 2003, 186:57-62.
48. Lee N, Millender LE, Larson DA, et al.: Gamma knife radiosurgery for recurrent salivary gland malignancies involving the base of skull. Head Neck 2003, 25:210-216.
49. Schulz-Ertner D, Nikoggshan A, Jakel O, et al.: Feasibility and toxicity of combined photon and carbon ion radiotherapy for locally advanced adenoid cystic carcinoma. Int J Radiat Oncol Biol Phys 2003, 56:391-398.
50. Laramore GE, Krall JM, Griffin TW, et al.: Neutron versus photon irradiation for unresectabte salivary gland tumors: final report of an RTOG-MRC randomized clinical trial. Int J Radiat Oncol Biol Phys 1993, 27:235-240.
51. Douglas JG, Koh WJ, Austin-Seymour M, et al.: Treatment of salivary gland neoplasms with fast neutron radiotherapy. Arch Otolaryngol Head Neck Surg 2003, 129:944-948. This is a recent review of neutron radiotherapy in salivary gland cancer.
52. Sung MW, Kim KH, Kim JW, et al.: Clinicopathologic predictors and impact of distant metastasis from adenoid cystic carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg 2003, 129:1193-1197.
53. Friedrich RE, Bleckmann V: Adenoid cystic carcinoma of salivary gland origin, localization, classification, clinical pathological correlation, treatment results and long term follow-up control in 84 patients. Anticancer Res 2003, 23:931-940.
54. Van der Wal JE, Becking AG, Snow G, et al.: Distant metastases of adenoid cystic carcinoma of the salivary glands and the value of diagnostic examinations during follow-up. Head Neck 2002, 24:779-783.
55. Licitra L, Grandi C, Prott FJ, et al.: Major and minor salivary glands tumours. Crit Rev Oncol Hematol 2003, 45:215-225.
56. Locati LD, Tamborini E, Quattrone P, et al.: Tyrosine kinase and hormonal receptors as therapeutic molecular targets in salivary glands carcinomas (SGC) [abstract]. Proc Suppl AACR 2002.
57. Nasser SM, Faquin WC, Dayal Y: Expression of androgen, estrogen and progesterone receptors in salivary gland tumors. Frequent expression of androgen receptor in a subset of malignant salivary gland tumors. Am J Clin Pathol 2003, 119:801-806.
58. Jeng YM, Lin CY, Hsu HC: Expression of the c-kit protein is associated with certain subtypes of salivary gland carcinoma. Cancer Lett 2000, 154:107-111.
59. Holst VA, Marshall CE, Moskaluk CA, et al.: Kit protein expression and analysis of c-kit gene mutation in adenoid cystic carcinoma. Mod Pathol 1999, 12:956-960.
60. Winquist E, Lamont E, Hotte S, et al.: Phase II study of imatinib mesylate in salivary gland adenoid cystic carcinoma. Eur J Cancer 2003, 1:S46.
61. Skalova A, Starek I, Vanecek T, et al.: Expression of HER-2 /neu gene and protein in salivary duct carcinomas of parotid gland as revealed by fluorescence in situ hybridization and immunohistochemistry. Histopathology 2003, 42:348-356.
62. Haddad R, Colevas AD, Krane JF, et al.: Herceptin in patients with advanced or metastatic salivary gland carcinomas. Oral Oncol 2003, 39:724-727.
63. van der Hulst RW, van Krieken JH, van der Kwast TH, et al.: Partial remission of parotid gland carcinoma after goserelin. Lancet 1994, 344:817.
64. Locati LD, Mela M, Quattrone P, et al.: Anti-androgen therapy in recurrent and/or metastatic salivary glands carcinoma (RSGC). Ann Oncol 2003, 14(suppl 4):iv126.